Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27656325

CC(C)(C)OC=O.Fc1ccc(N2CCNCC2)c2ccccc12

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 12/20 0.48
NCF1 P14598 3/20 0.43
HTR3E A5X5Y0 2/20 0.43
HTR3B O95264 2/20 0.43
HTR3A P46098 2/20 0.43
HTR3D Q70Z44 2/20 0.43
HTR3C Q8WXA8 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
CYP1A2 P05177 1/20 0.43
HTR1A P08908 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43
HTR2A P28223 1/20 0.43
HTR7 P34969 1/20 0.43
MTOR P42345 1/20 0.43
HTR5A P47898 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27656471 0.85 HTR6 (0.70) HTR6NCF1HTR3EHTR3BHTR3A
SCHEMBL5362969 0.84 HTR6 (0.65) HTR6NCF1HTR3EHTR3BHTR3A
Tert-Butyl Formate SCHEMBL27656379 0.81 HTR6 (0.42) HTR6NCF1HTR3EHTR3BHTR3A
Tert-Butyl Formate SCHEMBL27635294 0.80 ADRB1 (0.50) HTR6NCF1HTR3EHTR3BHTR3A
Tert-Butyl Formate SCHEMBL27635279 0.80 HTR6 (0.47) HTR6NCF1HTR3EHTR3BHTR3A
Tert-Butyl Formate SCHEMBL27588079 0.78 HTR5A (0.41) HTR6HTR3EHTR3BHTR3AHTR3D
Tert-Butyl Formate SCHEMBL28761806 0.77 NCF1 (0.44) HTR6NCF1HTR3EHTR3BHTR3A
Tert-Butyl Formate SCHEMBL27974539 0.76 ADRB1 (0.47) HTR6NCF1HTR3EHTR3BHTR3A
Tert-Butyl Formate SCHEMBL27790951 0.76 ADRB1 (0.47) HTR6HTR3EHTR3BHTR3AHTR3D
Tert-Butyl Formate SCHEMBL28256684 0.76 ALDH1A1 (0.40) HTR6HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100422181-C [1,8] naphthyridin-2-ones and related compounds for the treatment of schizophrenia WARNER LAMBERT CO (US) 2008-10-01 CN disclosed
CN-1839134-A [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia WARNER LAMBERT CO (US) 2006-09-27 CN disclosed